Maximum androgen blockade with abiraterone, by Charles J. Ryan, MD - Case Lecture Presentation

Charles Ryan

BERKELEY, CA USA ( - Presented by Charles J. Ryan, MD, Associate Professor of Medicine and Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.  The case lecture presentation will take approximately 30 minutes to complete.



Related Presentations:

- The impact of abiraterone acetate therapy on patient-reported pain and functional status in chemotherapy-naive patients with progressive, metastatic castration-resistant prostate cancer, by Charles J. Ryan, MD

View Presentation...

- Treatment of chemotherapy-naive metastatic castration-resistant prostate cancer - Case Lecture Presentation

View Presentation...

Learn More About mCRPC Treatment

 all mcrpc button

- Successful treatment of advanced metastatic prostate cancer following chemotherapy based on molecular profiling, "Beyond the Abstract," by Charles E. Myers, MD


- Advances in the treatment of prostate cancer - dawn of a new era - Abstract


- Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases - Abstract


- Non-metastatic CRPC and asymptomatic metastatic CRPC: Which treatment for which patient? - Abstract




Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.